NASDAQ / LIVE COMPANY INTELLIGENCE

Revelation Biosciences, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERREVB
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / REVB COVERAGE

What’s moving Revelation Biosciences, Inc. now

Current reporting with the operating signal separated from the noise.

01
Revelation Biosciences, Inc.: Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635

Revelation Biosciences, Inc.: Revelation Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635

The story matters when it changes Revelation Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026

Revelation Biosciences, Inc. Announces Financial Results For the Three Months Ended March 31, 2026

The story matters when it changes Revelation Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

Revelation Biosciences, Inc. Announces Financial Results for the Three and Nine Months Ended September 30, 2025

The story matters when it changes Revelation Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

Revelation Biosciences, Inc. Announces Pricing of $4 Million Public Offering

The story matters when it changes Revelation Biosciences, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest REVB filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-06 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-13 · Period 2026-07-10SEC ↗8-KMaterial company eventFiled 2026-06-24 · Period 2026-06-24SEC ↗8-KMaterial company eventFiled 2026-06-01 · Period 2026-06-01SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-05-11 · Period 2026-06-24SEC ↗8-A12BOfficial SEC filingFiled 2026-07-13SEC ↗
EARNINGS / QUARTERLY TRACKER

Revelation Biosciences, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.